Literature DB >> 24776220

A critical role of non-classical MHC in tumor immune evasion in the amphibian Xenopus model.

Nikesha Haynes-Gilmore1, Maureen Banach2, Eva-Stina Edholm2, Edith Lord2, Jacques Robert3.   

Abstract

Non-classical class Ib (class Ib) genes are found in all jawed vertebrates, including the amphibian Xenopus, which possesses at least 20 distinct Xenopus non-classical class Ib genes (XNCs). As an immune evasion strategy, tumors often downregulate surface expression of classical major histocompatibility complex class Ia molecules. In contrast, cancers commonly express class Ib molecules, presenting an alternative for tumor immune recognition. We characterized a novel XNC, XNC10, functionally similar to CD1d from a class Ia-deficient thymic lymphoid tumor (15/0), which grows aggressively in Xenopus LG-15 cloned animals. To investigate the roles of XNC10 in antitumor immunity, we generated stable 15/0-transfectants with silenced XNC10 mRNA and protein expression. Notably, XNC10 silencing resulted in acute tumor rejection by naturally class Ia-deficient syngeneic tadpoles, with greater potency of rejection in tumors with more efficient XNC10 knockdown. In vivo killing assays shows that the rejection of XNC10-deficient tumors is due to a cell-mediated cytotoxic immune response elicited by the tadpole host. Importantly, priming enhances XNC10-deficient tumor rejection. Flow cytometry reveals that XNC10-deficient tumor rejection is associated with an accumulation of XNC10-restricted invariant T cells and conventional CD8 T cells as well as other leukocytes. Similarly, semisolid tumor grafts in tadpoles also exhibit leukocytes infiltration. These findings suggest that XNC10 allows the 15/0-tumor to escape immune recognition and class Ia-independent cytotoxicity, thus emphasizing the critical roles of class Ibs in tumor immunity.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24776220      PMCID: PMC4123649          DOI: 10.1093/carcin/bgu100

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  31 in total

Review 1.  Stress management: MHC class I and class I-like molecules as reporters of cellular stress.

Authors:  Michael Gleimer; Peter Parham
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

2.  Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.

Authors:  S Ugurel; V Rebmann; S Ferrone; W Tilgen; H Grosse-Wilde; U Reinhold
Journal:  Cancer       Date:  2001-07-15       Impact factor: 6.860

3.  Loss of MHC class-I expression in cervical carcinomas.

Authors:  M E Connor; P L Stern
Journal:  Int J Cancer       Date:  1990-12-15       Impact factor: 7.396

4.  The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis.

Authors:  Eugene Y Chiang; Maile Henson; Iwona Stroynowski
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

5.  Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.

Authors:  Terrence L Fisher; MaryAnn Nocera; Richard A Willis; Michael J Turner; C Siddiq Abdul Alim; Deborah M Brown; Patricia A Bourne; P Anthony di Sant'Agnese; Edward M Messing; Edith M Lord; John G Frelinger
Journal:  Prostate       Date:  2002-05-15       Impact factor: 4.104

6.  A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.

Authors:  Heinz Wiendl; Meike Mitsdoerffer; Valeska Hofmeister; Jörg Wischhusen; Antje Bornemann; Richard Meyermann; Elisabeth H Weiss; Arthur Melms; Michael Weller
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

7.  A nonclassical MHC class I molecule restricts CTL-mediated rejection of a syngeneic melanoma tumor.

Authors:  Eugene Y Chiang; Iwona Stroynowski
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

8.  Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors.

Authors:  E J Lepin; J M Bastin; D S Allan; G Roncador; V M Braud; D Y Mason; P A van der Merwe; A J McMichael; J I Bell; S H Powis; C A O'Callaghan
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

Review 9.  HLA class I defects in malignant lesions: what have we learned?

Authors:  Chien-Chung Chang; Michael Campoli; Soldano Ferrone
Journal:  Keio J Med       Date:  2003-12

10.  Nonclassical MHC class I-dependent invariant T cells are evolutionarily conserved and prominent from early development in amphibians.

Authors:  Eva-Stina Edholm; Liz-Marie Albertorio Saez; Ann L Gill; Steven R Gill; Leon Grayfer; Nikesha Haynes; Jason R Myers; Jacques Robert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

View more
  12 in total

Review 1.  MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?

Authors:  Stanislas Mondot; Pierre Boudinot; Olivier Lantz
Journal:  Immunogenetics       Date:  2016-07-08       Impact factor: 2.846

Review 2.  Expanding the genetic toolkit in Xenopus: Approaches and opportunities for human disease modeling.

Authors:  Panna Tandon; Frank Conlon; J David Furlow; Marko E Horb
Journal:  Dev Biol       Date:  2016-04-22       Impact factor: 3.582

3.  Impacts of the MHC class I-like XNC10 and innate-like T cells on tumor tolerance and rejection in the amphibian Xenopus.

Authors:  Maureen Banach; Eva-Stina Edholm; Xavier Gonzalez; Abdellatif Benraiss; Jacques Robert
Journal:  Carcinogenesis       Date:  2019-07-20       Impact factor: 4.944

4.  Tumor immunology viewed from alternative animal models-the Xenopus story.

Authors:  Maureen Banach; Jacques Robert
Journal:  Curr Pathobiol Rep       Date:  2017-01-26

Review 5.  Evolution of nonclassical MHC-dependent invariant T cells.

Authors:  Eva-Stina Edholm; Leon Grayfer; Jacques Robert
Journal:  Cell Mol Life Sci       Date:  2014-08-14       Impact factor: 9.261

6.  Semi-solid tumor model in Xenopus laevis/gilli cloned tadpoles for intravital study of neovascularization, immune cells and melanophore infiltration.

Authors:  Nikesha Haynes-Gimore; Maureen Banach; Edward Brown; Ryan Dawes; Eva-Stina Edholm; Minsoo Kim; Jacques Robert
Journal:  Dev Biol       Date:  2015-01-17       Impact factor: 3.582

Review 7.  Evolution of innate-like T cells and their selection by MHC class I-like molecules.

Authors:  Eva-Stina Edholm; Maureen Banach; Jacques Robert
Journal:  Immunogenetics       Date:  2016-07-01       Impact factor: 2.846

Review 8.  A prominent role for invariant T cells in the amphibian Xenopus laevis tadpoles.

Authors:  Jacques Robert; Eva-Stina Edholm
Journal:  Immunogenetics       Date:  2014-06-05       Impact factor: 2.846

9.  Exploring the functions of nonclassical MHC class Ib genes in Xenopus laevis by the CRISPR/Cas9 system.

Authors:  Maureen Banach; Eva-Stina Edholm; Jacques Robert
Journal:  Dev Biol       Date:  2016-06-16       Impact factor: 3.582

Review 10.  An oncologist׳s friend: How Xenopus contributes to cancer research.

Authors:  Laura J A Hardwick; Anna Philpott
Journal:  Dev Biol       Date:  2015-02-19       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.